Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study

2018 ◽  
Vol 33 (8) ◽  
pp. 1272-1280 ◽  
Author(s):  
Donald L. Gilbert ◽  
Tanya K. Murphy ◽  
Joseph Jankovic ◽  
Cathy L. Budman ◽  
Kevin J. Black ◽  
...  
Keyword(s):  
Crossover Study ◽  
Receptor Antagonist ◽  
Tourette Syndrome ◽  
D1 Receptor ◽  
D1 Receptor Antagonist

A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome

2014 ◽  
pp. 1 ◽  
Author(s):  
Donald L. Gilbert ◽  
Cathy L. Budman ◽  
Harvey S. Singer ◽  
Roger Kurlan ◽  
Richard E. Chipkin
Keyword(s):  
Receptor Antagonist ◽  
Tourette Syndrome ◽  
D1 Receptor ◽  
D1 Receptor Antagonist

The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys

Life Sciences ◽  
1991 ◽  
Vol 49 (25) ◽  
pp. PL229-PL234 ◽  
Author(s):  
Matthew S. Lawrence ◽  
D.Eugene Redmond ◽  
J.D. Elsworth ◽  
J.R. Taylor ◽  
R.H. Roth
Keyword(s):  
Receptor Antagonist ◽  
Sch 23390 ◽  
D1 Receptor ◽  
D1 Receptor Antagonist ◽  
Green Monkeys
Sign in / Sign up

Export Citation Format

Share Document